Dixon Hubard Feinour & Brown Inc Laboratory Corp Of America Holdings Transaction History
Dixon Hubard Feinour & Brown Inc
- $842 Million
- Q2 2022
A detailed history of Dixon Hubard Feinour & Brown Inc transactions in Laboratory Corp Of America Holdings stock. As of the latest transaction made, Dixon Hubard Feinour & Brown Inc holds 1,675 shares of LH stock, worth $382,921. This represents 0.05% of its overall portfolio holdings.
Number of Shares
1,675
Previous 1,675
-0.0%
Holding current value
$382,921
Previous $442,000
11.09%
% of portfolio
0.05%
Previous 0.04%
Shares
3 transactions
Others Institutions Holding LH
# of Institutions
95Shares Held
1.94MCall Options Held
0Put Options Held
0-
Jana Partners LLC New York, NY402KShares$91.9 Million7.25% of portfolio
-
Cannell & Co. New York, NY341KShares$77.9 Million2.57% of portfolio
-
Bartlett & Co. LLC223KShares$50.9 Million0.82% of portfolio
-
Atlanta Capital Management CO L L C Atlanta, GA198KShares$45.2 Million0.18% of portfolio
-
Credit Suisse Ag Zurich, V8141KShares$32.3 Million0.03% of portfolio
About LABORATORY CORP OF AMERICA HOLDINGS
- Ticker LH
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 89,600,000
- Market Cap $20.5B
- Description
- Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...